What happened to DoorDash's stock?

DoorDash's stock jumped 6% after the delivery platform announced a partnership with apparel retailer Old Navy, marking a move beyond its core restaurant delivery business.

How did Micron Technology perform in the markets?

Micron Technology's stock gained 4.2% after Morgan Stanley named it a "top pick" and boosted its price target, citing a surge in pricing for the company's memory chips, especially its Double Data Rate 5 products, which are seeing strong demand related to the buildout of AI data centers.

Home / Business and Economy / Delivery Surge and Pharma Setback Shake Up Markets

Delivery Surge and Pharma Setback Shake Up Markets

Q: Why did Bristol-Myers Squibb's stock drop?

Bristol-Myers Squibb's stock dropped 4.1% after the company said it would discontinue a late-stage clinical trial of an experimental heart treatment called milvexian, which it was developing in collaboration with Johnson & Johnson.

15 Nov

•

Summary

DoorDash stock jumps 6% on new Old Navy partnership
Bristol-Myers Squibb ends heart drug trial, shares drop 4.1%
Micron Technology named a "top pick" by Morgan Stanley

Delivery Surge and Pharma Setback Shake Up Markets

On Friday, November 14, 2025, the markets saw a mix of fortunes for major companies. Delivery giant DoorDash saw its stock surge 6% after announcing a partnership with clothing retailer Old Navy, marking a move beyond its core restaurant delivery business.

In contrast, pharmaceutical firm Bristol-Myers Squibb faced a setback as it ended a late-stage clinical trial of an experimental heart treatment called milvexian, which it was developing in collaboration with Johnson & Johnson. Shares of Bristol-Myers Squibb dropped 4.1% on the news.

Elsewhere, memory chip manufacturer Micron Technology received a boost, with Morgan Stanley naming it a "top pick" and raising its price target. Analysts cited strong demand for Micron's Double Data Rate 5 products, particularly related to the buildout of AI data centers.